St. Jude Medical (STJ) 67.48 $STJ
Dividend Challengers (And Near-Challengers): 67 Increases Expected By April 30
David Fish - at Seeking Alpha - Fri Feb 13, 7:16PM CST
KSS: 68.25 (-0.58), CNS: 41.45 (-0.70), PDCO: 50.65 (-0.16), NSU: 3.73 (+0.13), LYB: 89.99 (+0.19), MYE: 17.61 (+0.01), SCS: 18.43 (+0.07), PNC: 92.38 (+0.82), INDB: 40.25 (+0.03), MOV: 25.26 (-0.17), TMK: 54.05 (+0.35), ROIC: 17.27 (-0.08), TYC: 43.19 (+0.27), SYA: 22.86 (-0.14), SPTN: 25.99 (+0.14), ETN: 72.55 (+0.90), HMN: 31.40 (-0.11), ATLO: 24.93 (-0.06), SIG: 120.19 (+0.36), STWD: 24.24 (-0.10), IEX: 77.14 (+0.77), MJN: 101.89 (+2.32), BGS: 29.60 (-0.44), FCZA: 10.75 (+0.30), STJ: 67.48 (+0.65), MGA: 102.32 (-0.46), IEP: 100.21 (+0.28), MELI: 129.99 (-1.95), NRF: 18.65 (+0.12), OXM: 53.69 (-0.93), SNI: 73.00 (+0.39), LMAT: 7.66 (+0.08), PLOW: 21.90 (+0.32), FL: 53.96 (-0.13), EMCF: 24.03 (-0.87), BK: 39.20 (-0.21), HRC: 46.88 (+0.14), TXRH: 34.59 (+0.07), HD: 111.89 (-0.27), KW: 27.50 (+0.25), HSBC: 46.13 (-0.01), FMC: 63.68 (+0.44), LEA: 108.70 (-0.73), FFG: 58.39 (+0.25), RS: 55.14 (+1.36), HPY: 49.42 (-5.71), JWN: 79.41 (+0.04), FLS: 59.31 (+1.00), MTN: 85.85 (-0.82), ENH: 64.63 (+0.15), MLR: 21.11 (-0.08), CMCSA: 59.47 (+1.09), SSW: 18.50 (+0.45)
LifeScience Alley Board of Directors Elects New Officers
Business Wire - Thu Feb 12, 9:31AM CST
Following the annual meeting of its board of directors, LifeScience Alley announces the election of the following officers: Robert Kieval, executive vice president and chief technology officer of CVRx, Inc., has been named as the chair of the board. Rachel Ellingson, vice president of global communications for St. Jude Medical and president of the St. Jude Medical Foundation, has been elected to serve as vice chair. Additionally, Kevin Smith, partner at KPMG, LLP, and Steven Mertens, senior vice president of operations for Holaira, have been re-elected to serve as treasurer and secretary, respectively.
STJ: 67.48 (+0.65)
St. Jude Medical HALO US IDE Trial Tests 15mm Heart Valves - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 3:13PM CST
Global medical devices company, St. Jude Medical (STJ), recently launched the HALO U.S. IDE Trial.
CSII: 35.69 (+0.17), PAHC: 30.85 (+0.36), ABAX: 60.93 (+0.65), STJ: 67.48 (+0.65)
Amid Alleged Pacemaker Lead Defects, Schubert Jonckheer & Kolbe LLP Investigates St. Jude Medical's Top Executives
PR Newswire - Tue Feb 10, 10:00AM CST
Shareholder and consumer rights law firm Schubert Jonckheer & Kolbe LLP has launched an investigation into whether certain officers and directors of St. Jude Medical, Inc. (NYSE: STJ) breached their fiduciary duties to St. Jude and its shareholders.
STJ: 67.48 (+0.65)
Patient Monitoring Global Market 2015 - Forecast to 2020
M2 - Tue Feb 10, 8:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/vvvf8m/patient) has announced the addition of the "Patient Monitoring Global Market - Forecast to 2020" report to their offering. The global patient monitoring devices market is expected to reach approximately $24 billion by 2019 growing at CAGR of around 8.0%. North America commands the largest share and is expected to register a healthy market share by 2019. APAC is going to be one of the prominent regions for this market in coming years driven by the increased purchasing power and rising population. Patient monitoring is essential part of care process together with administration of therapy. The main aim of monitoring is to make sure that proper care [or] therapy can be given in advance to the arrival of complications. Patient monitoring is essential to take care in emergency and operating rooms, intensive and critical care units and it is extremely useful for recovery rooms, respiration therapy, radiology, outpatient care, and gastroenterology department, Transport, Home and sleep screening applications. Patient monitoring play key role to reduce complications, risks, infections as well assist in providing for patient comfort. Patient monitoring devices market is mainly divided into following segments such as Hemodynamic, neurology, respiratory, Cardiology, fetal and neonatal, multi parameters, remote patient monitors, temperature and weight monitors. Some of the key players in this market are Abbott Laboratories (U.S.), GE Health care (U.K.), Johnson & Johnson, Inc. (U.S.), Covidien (Ireland), Mindray Medical (China), Philips Healthcare (Netherlands), Drager Medical GmbH (Germany), and Roche Diagnostics Limited (Switzerland). Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Global Patient Monitoring System Market, By Device 5 Global Patient Monitoring System Market, By End-Users 6 Regional Market Analysis 7 Company Developments 8 Major Company Profiles - Abbott Laboratories - Boston Scientific Corpoartion - Covidien Plc - Ge Healthcare - Johnson & Johnson - Medtronic Inc. - Omron Healthcare, Inc. - Philips Healthcare - Roche Ltd. - St. Jude Medical, Inc. Visit http://www.researchandmarkets.com/research/vvvf8m/patient
BSX: 14.98 (+0.24), JNJ: 99.62 (+1.18), ABT: 46.09 (+0.87), MDT: 75.26 (+0.33), STJ: 67.48 (+0.65)
St. Jude Medical Launches U.S. Study of the Country's Smallest Pediatric Mechanical Heart Valve
Business Wire - Tue Feb 10, 8:07AM CST
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the launch of the HALO U.S. IDE Trial. The trial will evaluate the safety and efficacy of the St. Jude Medical Masters HP(TM) Series 15mm mechanical heart valve, the smallest pediatric mechanical heart valve in the world. The HALO Trial will enroll pediatric patients in need of mitral valve replacement who cannot be implanted with the current range of approved valves without additional risks and who have no alternative approved treatment options.
STJ: 67.48 (+0.65)
Global Angiography Devices (Angiography systems, Catheters, Guide-Wires, Balloons, Contrast Media, Accessories) Market 2014-2019
M2 - Tue Feb 10, 5:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/66llkk/angiography) has announced the addition of the "Angiography Devices Market by Technology, Products, Application & End-Users - Global Forecast to 2019" report to their offering. The global angiography devices market is estimated to reach $27.7 billion in 2019, at a CAGR of 4.4% from 2014 to 2019 Angiography is a medical imaging procedure used to visualize blood vessels (arteries and veins) inside the body. Angiography devices are used to diagnose and evaluate many diseases of blood vessels and related conditions, such as injuries, aneurysms (ballooning of a blood vessel), blockages (due to blood clots or plaques), stenosis (narrowing of a blood vessel), congenital (birth-related) heart abnormalities, disorganized blood vessels, and blood supply to tumors. Images captured trough angiography is called as angiograms. The angiography devices market is mainly driven by technological advances, innovative product offerings, and growing aging population and increasing prevalence of vascular diseases. However, the lack of reimbursement for these systems and the presence of stringent regulations are expected to restrain the growth of this market in the forecast period. The angiography devices market in this report is broadly segmented by technology, products, applications, procedures, indications, and end users. The market, by products, is segmented into angiography systems, catheters, guide-wires, balloons, contrast media, vascular closure devices, and accessories. The market by technology is segmented into X-ray, computed tomography, and magnetic resonance angiography. Based on applications the market is segmented as diagnostic and therapeutic. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Angiography Devices Market, By Technology 7 Angiography Devices Market, By Products 8 Angiography Devices Market, By Type Of Application 9 Angiography Devices Market, By Procedure 10 Angiography Devices Market, By Indication 11 Angiography Devices Market, By End-Users 12 Geography Analysis 13 Competitive Landscape 14 Company Profiles - Abbott Vascular - Boston Scientific Corporation - Cordis Corporation (A Jnj Company) - GE Healthcare - Medtronic Inc. - Philips Healthcare - ST. Jude Medical - Shimadzu Corporation - Siemens Healthcare - Toshiba Corporation For more information visit http://www.researchandmarkets.com/research/66...ngiography
BSX: 14.98 (+0.24), MDT: 75.26 (+0.33), STJ: 67.48 (+0.65)
U.S. & European Heart Valve Market Overview 2014
M2 - Tue Feb 10, 5:16AM CST
Research and Markets (http://www.researchandmarkets.com/research/l83sqr/u_s_and_european) has announced the addition of the "U.S. & European Heart Valve Market" report to their offering. The surgical heart valve market consists of both mechanical and tissue heart valves. Tissue heart valves consist of stented, stentless and sutureless tissue heart valves. Stented heart valves have long been the industry standard; however, stentless and sutureless valves are expected to show a strong presence over the forecast period. A sutureless valve differs from traditional tissue heart valves in that it is self-anchoring and thus does not need to be sutured in place. Thus, sutureless heart valves require a shorter procedure time than traditional tissue heart valves, and are able to be delivered minimally invasively. The sutureless heart valve market is expected to increase its share approximately threefold. The market has a competitive landscape with each competitor having quality and clinically supported products available. A critical note for the surgical heart valve market is that the growth of the transcatheter heart valve implantation device market has not had a substantial impact on the demand for surgical heart valves, indicating that the various valve technologies treat different patient populations. Key Topics Covered: 1. Research Methodology 2. Heart Valve Device And Procedure Overview 3. U.S. Tissue Heart Valve Market 4. European Tissue Heart Valve Market 5. U.S. Mechanical Heart Valve Market 6. European Mechanical Heart Valve Market 7. U.S. Annuloplasty Repair Device Market 8. European Annuloplasty Repair Device Market 9. U.S. Transcatheter Mitral Valve Repair Device Market 10. European Transcatheter Mitral Valve Repair Market 11. U.S. Transcatheter Heart Valve Implantation Device Market 12. European Transcatheter Heart Valve Implantation Device Market Companies Mentioned - Cardiac Dimensions - Cardiosolutions - CryoLife - Direct Flow Medical - Edwards LifeSciences - Endovalve Inc - JenaValve - JenaValve Technology - Medtronic - MiCardia - Sandra Medical - Sorin - St. Jude Medical For more information visit http://www.researchandmarkets.com/research/l8...d_european
MDT: 75.26 (+0.33), STJ: 67.48 (+0.65), EW: 134.23 (+1.89), CRY: 11.30 (-0.10)
Viveve Appoints James Atkinson Chief Business Officer/President
Marketwired - Mon Feb 09, 3:30PM CST
Viveve Medical, Inc. ("Viveve"
(OTCQB: VIVMF), a company focused on women's health, today announced that James Atkinson has joined the company as Chief Business Officer and President. In this newly created position, Mr. Atkinson will provide strategic leadership in building the company's global distribution network, positioning Viveve for strong market expansion worldwide. In addition, he will serve as a member of Viveve's executive leadership team where he will contribute to the formulation and execution of the company's strategic vision.
STJ: 67.48 (+0.65)
Global Spinal Cord Stimulation (Rechargeable SCS System & Non-Rechargeable SCS System) Market Trends & Opportunities 2014-19
M2 - Mon Feb 09, 5:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/t3fksk/global_spinal) has announced the addition of the "Global Spinal Cord Stimulation Market: Trends & Opportunities (2014-19)" report to their offering. The report Global Spinal Cord Stimulation Market: Trends and Opportunities (2014-2019) provides an in-depth analysis of the global Spinal cord Stimulation market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth. It also assesses the key opportunities and underlying trends in the market and outlines the factors that are and will be driving the growth of the industry in the forecasted period (2014-19). The report also assesses the main types of SCS devices - the rechargeable and non-rechargeable spinal cord stimulation devices. Further, key players of the industry like Boston Scientific Corporation, St. Jude Medical and Medtronic have been profiled and analyzed in the report. Spinal cord stimulation (SCS) is a pain relief technique that delivers a low-voltage electrical current continuously to the spinal cord to block the sensation of pain. SCS is the most commonly used implantable neuro-stimulation technology for management of pain syndromes. The growth of the global Spinal cord Stimulation market is driven by a number of factors that include rise in ageing demographics, rising healthcare expenditure per capita, growing cases of obesity and increasing number of failed surgeries. Acknowledging these factors, it could be said that the Spinal cord Stimulation market business will certainly gain importance in the years to come. Strict regulations, environment issues, dearth of expertise and trained healthcare workers and several other issues pose major challenge to the growth of this business. Major trends prevailing in the spinal cord stimulation market are advancement in spine surgery, changing surgeon preferences, mergers & acquisitions and incidence of pain conditions in the US households. Company Coverage - Boston Scientific - Nevro - St. Jude Medical - Medtronic Key Topics Covered: 1. Executive Summary 2. Spinal Cord Injuries and Stimulation: An Introduction 3. Global Spinal Cord Stimulation Market Analysis 4. Spinal Cord Stimulation Market: Segment Analysis 5. The US Spinal Cord Stimulation Market 6. Global Spinal Cord Stimulation Market dynamics 8. Competitive Landscape: Spinal Cord Stimulation Market 9. Company Profiles: Spinal Cord Stimulation Market For more information visit http://www.researchandmarkets.com/research/t3...bal_spinal
BSX: 14.98 (+0.24), MDT: 75.26 (+0.33), STJ: 67.48 (+0.65)
Look for Shares of St Jude Medical to Potentially Rebound after Yesterday's 2.20% Sell Off
Comtex SmarTrend(R) - Fri Feb 06, 4:16PM CST
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $65.95 to a high of $67.98. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $66.31 on volume of 3.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
STJ: 67.48 (+0.65)
SmarTrend Watching for Potential Rebound in Shares of St Jude Medical After 2.20% Loss
Comtex SmarTrend(R) - Fri Feb 06, 4:15PM CST
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $65.95 to a high of $67.98. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $66.31 on volume of 3.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
STJ: 67.48 (+0.65)
Insider Trading Alert - BERY, STJ And FLXS Traded By Insiders
at The Street - Thu Feb 05, 11:17AM CST
Stocks with insider trader activity include BERY, STJ and FLXS
BERY: 34.98 (+0.03), FLXS: 31.00 (unch), STJ: 67.48 (+0.65)
Hansen Medical Announces Expanded Protocol for the ARTISAN AF IDE Study
Marketwired - Thu Feb 05, 8:01AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced FDA approval of an expanded protocol for the ARTISAN-AF IDE Study. The amended protocol now includes the use of the Thermocool(R) SmartTouch(R) Catheter (BioSense Webster, Diamond Bar, CA) and the EnSite Velocity Cardiac Mapping System (St. Jude Medical, St. Paul, MN). These technologies are used in conjunction with the Sensei(R) Robotic System to complete ablation procedures for the treatment of paroxysmal atrial fibrillation per the IDE study protocol.
HNSN: 1.05 (+0.02), STJ: 67.48 (+0.65)
Global Electrophysiology Devices Industry Report 2015 - Forecasts to 2020
M2 - Thu Feb 05, 6:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/v7rdl9/global) has announced the addition of the "Global Electrophysiology Devices Industry Report 2015" report to their offering. The Global Electrophysiology Devices Industry Report 2015 is a professional and in-depth study on the current state of the electrophysiology devices Industry with a focus on the Chinese situation. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The electrophysiology devices market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Electrophysiology devices industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on thirteen industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The electrophysiology devices industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: - Electrophysiology Devices Industry Overview - Electrophysiology Devices International and China Market Analysis - Electrophysiology Devices Technical Data and Manufacturing Plants Analysis - Electrophysiology Devices Production by Regions by Technology by Applications - Electrophysiology Devices Manufacturing Process and Cost Structure - Electrophysiology Devices Productions Supply Sales Demand Market Status and Forecast 2009-2014 - Electrophysiology Devices Key Manufacturers Analysis - Up and Down Stream Industry Analysis - Electrophysiology Devices Marketing Channels Analysis - Electrophysiology Devices Industry Development Trend - Electrophysiology Devices Industry Development Proposals - Electrophysiology Devices New Project Investment Feasibility Analysis - Global and China Electrophysiology Devices Industry Research Conclusions Companies Mentioned - Biotronik - Boston Scientific - GE Healthcare - HTONG - Huanan Medical - JJET - Johnson & Johnson - Medtronic Inc - Micro Port - Natus - Nihon Kohden - Philips Healthcare - St. Jude Medical,Inc. For more information visit http://www.researchandmarkets.com/research/v7rdl9/global
BSX: 14.98 (+0.24), JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), STJ: 67.48 (+0.65)
Dividend Challengers (And Near-Challengers): 67 Increases Expected By April 30
David Fish - at Seeking Alpha - Fri Feb 13, 7:16PM CST
KSS: 68.25 (-0.58), CNS: 41.45 (-0.70), PDCO: 50.65 (-0.16), NSU: 3.73 (+0.13), LYB: 89.99 (+0.19), MYE: 17.61 (+0.01), SCS: 18.43 (+0.07), PNC: 92.38 (+0.82), INDB: 40.25 (+0.03), MOV: 25.26 (-0.17), TMK: 54.05 (+0.35), ROIC: 17.27 (-0.08), TYC: 43.19 (+0.27), SYA: 22.86 (-0.14), SPTN: 25.99 (+0.14), ETN: 72.55 (+0.90), HMN: 31.40 (-0.11), ATLO: 24.93 (-0.06), SIG: 120.19 (+0.36), STWD: 24.24 (-0.10), IEX: 77.14 (+0.77), MJN: 101.89 (+2.32), BGS: 29.60 (-0.44), FCZA: 10.75 (+0.30), STJ: 67.48 (+0.65), MGA: 102.32 (-0.46), IEP: 100.21 (+0.28), MELI: 129.99 (-1.95), NRF: 18.65 (+0.12), OXM: 53.69 (-0.93), SNI: 73.00 (+0.39), LMAT: 7.66 (+0.08), PLOW: 21.90 (+0.32), FL: 53.96 (-0.13), EMCF: 24.03 (-0.87), BK: 39.20 (-0.21), HRC: 46.88 (+0.14), TXRH: 34.59 (+0.07), HD: 111.89 (-0.27), KW: 27.50 (+0.25), HSBC: 46.13 (-0.01), FMC: 63.68 (+0.44), LEA: 108.70 (-0.73), FFG: 58.39 (+0.25), RS: 55.14 (+1.36), HPY: 49.42 (-5.71), JWN: 79.41 (+0.04), FLS: 59.31 (+1.00), MTN: 85.85 (-0.82), ENH: 64.63 (+0.15), MLR: 21.11 (-0.08), CMCSA: 59.47 (+1.09), SSW: 18.50 (+0.45)
LifeScience Alley Board of Directors Elects New Officers
Business Wire - Thu Feb 12, 9:31AM CST
Following the annual meeting of its board of directors, LifeScience Alley announces the election of the following officers: Robert Kieval, executive vice president and chief technology officer of CVRx, Inc., has been named as the chair of the board. Rachel Ellingson, vice president of global communications for St. Jude Medical and president of the St. Jude Medical Foundation, has been elected to serve as vice chair. Additionally, Kevin Smith, partner at KPMG, LLP, and Steven Mertens, senior vice president of operations for Holaira, have been re-elected to serve as treasurer and secretary, respectively.
STJ: 67.48 (+0.65)
St. Jude Medical HALO US IDE Trial Tests 15mm Heart Valves - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 3:13PM CST
Global medical devices company, St. Jude Medical (STJ), recently launched the HALO U.S. IDE Trial.
CSII: 35.69 (+0.17), PAHC: 30.85 (+0.36), ABAX: 60.93 (+0.65), STJ: 67.48 (+0.65)
Amid Alleged Pacemaker Lead Defects, Schubert Jonckheer & Kolbe LLP Investigates St. Jude Medical's Top Executives
PR Newswire - Tue Feb 10, 10:00AM CST
Shareholder and consumer rights law firm Schubert Jonckheer & Kolbe LLP has launched an investigation into whether certain officers and directors of St. Jude Medical, Inc. (NYSE: STJ) breached their fiduciary duties to St. Jude and its shareholders.
STJ: 67.48 (+0.65)
Patient Monitoring Global Market 2015 - Forecast to 2020
M2 - Tue Feb 10, 8:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/vvvf8m/patient) has announced the addition of the "Patient Monitoring Global Market - Forecast to 2020" report to their offering. The global patient monitoring devices market is expected to reach approximately $24 billion by 2019 growing at CAGR of around 8.0%. North America commands the largest share and is expected to register a healthy market share by 2019. APAC is going to be one of the prominent regions for this market in coming years driven by the increased purchasing power and rising population. Patient monitoring is essential part of care process together with administration of therapy. The main aim of monitoring is to make sure that proper care [or] therapy can be given in advance to the arrival of complications. Patient monitoring is essential to take care in emergency and operating rooms, intensive and critical care units and it is extremely useful for recovery rooms, respiration therapy, radiology, outpatient care, and gastroenterology department, Transport, Home and sleep screening applications. Patient monitoring play key role to reduce complications, risks, infections as well assist in providing for patient comfort. Patient monitoring devices market is mainly divided into following segments such as Hemodynamic, neurology, respiratory, Cardiology, fetal and neonatal, multi parameters, remote patient monitors, temperature and weight monitors. Some of the key players in this market are Abbott Laboratories (U.S.), GE Health care (U.K.), Johnson & Johnson, Inc. (U.S.), Covidien (Ireland), Mindray Medical (China), Philips Healthcare (Netherlands), Drager Medical GmbH (Germany), and Roche Diagnostics Limited (Switzerland). Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Global Patient Monitoring System Market, By Device 5 Global Patient Monitoring System Market, By End-Users 6 Regional Market Analysis 7 Company Developments 8 Major Company Profiles - Abbott Laboratories - Boston Scientific Corpoartion - Covidien Plc - Ge Healthcare - Johnson & Johnson - Medtronic Inc. - Omron Healthcare, Inc. - Philips Healthcare - Roche Ltd. - St. Jude Medical, Inc. Visit http://www.researchandmarkets.com/research/vvvf8m/patient
BSX: 14.98 (+0.24), JNJ: 99.62 (+1.18), ABT: 46.09 (+0.87), MDT: 75.26 (+0.33), STJ: 67.48 (+0.65)
St. Jude Medical Launches U.S. Study of the Country's Smallest Pediatric Mechanical Heart Valve
Business Wire - Tue Feb 10, 8:07AM CST
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the launch of the HALO U.S. IDE Trial. The trial will evaluate the safety and efficacy of the St. Jude Medical Masters HP(TM) Series 15mm mechanical heart valve, the smallest pediatric mechanical heart valve in the world. The HALO Trial will enroll pediatric patients in need of mitral valve replacement who cannot be implanted with the current range of approved valves without additional risks and who have no alternative approved treatment options.
STJ: 67.48 (+0.65)
Global Angiography Devices (Angiography systems, Catheters, Guide-Wires, Balloons, Contrast Media, Accessories) Market 2014-2019
M2 - Tue Feb 10, 5:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/66llkk/angiography) has announced the addition of the "Angiography Devices Market by Technology, Products, Application & End-Users - Global Forecast to 2019" report to their offering. The global angiography devices market is estimated to reach $27.7 billion in 2019, at a CAGR of 4.4% from 2014 to 2019 Angiography is a medical imaging procedure used to visualize blood vessels (arteries and veins) inside the body. Angiography devices are used to diagnose and evaluate many diseases of blood vessels and related conditions, such as injuries, aneurysms (ballooning of a blood vessel), blockages (due to blood clots or plaques), stenosis (narrowing of a blood vessel), congenital (birth-related) heart abnormalities, disorganized blood vessels, and blood supply to tumors. Images captured trough angiography is called as angiograms. The angiography devices market is mainly driven by technological advances, innovative product offerings, and growing aging population and increasing prevalence of vascular diseases. However, the lack of reimbursement for these systems and the presence of stringent regulations are expected to restrain the growth of this market in the forecast period. The angiography devices market in this report is broadly segmented by technology, products, applications, procedures, indications, and end users. The market, by products, is segmented into angiography systems, catheters, guide-wires, balloons, contrast media, vascular closure devices, and accessories. The market by technology is segmented into X-ray, computed tomography, and magnetic resonance angiography. Based on applications the market is segmented as diagnostic and therapeutic. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Angiography Devices Market, By Technology 7 Angiography Devices Market, By Products 8 Angiography Devices Market, By Type Of Application 9 Angiography Devices Market, By Procedure 10 Angiography Devices Market, By Indication 11 Angiography Devices Market, By End-Users 12 Geography Analysis 13 Competitive Landscape 14 Company Profiles - Abbott Vascular - Boston Scientific Corporation - Cordis Corporation (A Jnj Company) - GE Healthcare - Medtronic Inc. - Philips Healthcare - ST. Jude Medical - Shimadzu Corporation - Siemens Healthcare - Toshiba Corporation For more information visit http://www.researchandmarkets.com/research/66...ngiography
BSX: 14.98 (+0.24), MDT: 75.26 (+0.33), STJ: 67.48 (+0.65)
U.S. & European Heart Valve Market Overview 2014
M2 - Tue Feb 10, 5:16AM CST
Research and Markets (http://www.researchandmarkets.com/research/l83sqr/u_s_and_european) has announced the addition of the "U.S. & European Heart Valve Market" report to their offering. The surgical heart valve market consists of both mechanical and tissue heart valves. Tissue heart valves consist of stented, stentless and sutureless tissue heart valves. Stented heart valves have long been the industry standard; however, stentless and sutureless valves are expected to show a strong presence over the forecast period. A sutureless valve differs from traditional tissue heart valves in that it is self-anchoring and thus does not need to be sutured in place. Thus, sutureless heart valves require a shorter procedure time than traditional tissue heart valves, and are able to be delivered minimally invasively. The sutureless heart valve market is expected to increase its share approximately threefold. The market has a competitive landscape with each competitor having quality and clinically supported products available. A critical note for the surgical heart valve market is that the growth of the transcatheter heart valve implantation device market has not had a substantial impact on the demand for surgical heart valves, indicating that the various valve technologies treat different patient populations. Key Topics Covered: 1. Research Methodology 2. Heart Valve Device And Procedure Overview 3. U.S. Tissue Heart Valve Market 4. European Tissue Heart Valve Market 5. U.S. Mechanical Heart Valve Market 6. European Mechanical Heart Valve Market 7. U.S. Annuloplasty Repair Device Market 8. European Annuloplasty Repair Device Market 9. U.S. Transcatheter Mitral Valve Repair Device Market 10. European Transcatheter Mitral Valve Repair Market 11. U.S. Transcatheter Heart Valve Implantation Device Market 12. European Transcatheter Heart Valve Implantation Device Market Companies Mentioned - Cardiac Dimensions - Cardiosolutions - CryoLife - Direct Flow Medical - Edwards LifeSciences - Endovalve Inc - JenaValve - JenaValve Technology - Medtronic - MiCardia - Sandra Medical - Sorin - St. Jude Medical For more information visit http://www.researchandmarkets.com/research/l8...d_european
MDT: 75.26 (+0.33), STJ: 67.48 (+0.65), EW: 134.23 (+1.89), CRY: 11.30 (-0.10)
Viveve Appoints James Atkinson Chief Business Officer/President
Marketwired - Mon Feb 09, 3:30PM CST
Viveve Medical, Inc. ("Viveve"
(OTCQB: VIVMF), a company focused on women's health, today announced that James Atkinson has joined the company as Chief Business Officer and President. In this newly created position, Mr. Atkinson will provide strategic leadership in building the company's global distribution network, positioning Viveve for strong market expansion worldwide. In addition, he will serve as a member of Viveve's executive leadership team where he will contribute to the formulation and execution of the company's strategic vision. STJ: 67.48 (+0.65)
Global Spinal Cord Stimulation (Rechargeable SCS System & Non-Rechargeable SCS System) Market Trends & Opportunities 2014-19
M2 - Mon Feb 09, 5:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/t3fksk/global_spinal) has announced the addition of the "Global Spinal Cord Stimulation Market: Trends & Opportunities (2014-19)" report to their offering. The report Global Spinal Cord Stimulation Market: Trends and Opportunities (2014-2019) provides an in-depth analysis of the global Spinal cord Stimulation market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth. It also assesses the key opportunities and underlying trends in the market and outlines the factors that are and will be driving the growth of the industry in the forecasted period (2014-19). The report also assesses the main types of SCS devices - the rechargeable and non-rechargeable spinal cord stimulation devices. Further, key players of the industry like Boston Scientific Corporation, St. Jude Medical and Medtronic have been profiled and analyzed in the report. Spinal cord stimulation (SCS) is a pain relief technique that delivers a low-voltage electrical current continuously to the spinal cord to block the sensation of pain. SCS is the most commonly used implantable neuro-stimulation technology for management of pain syndromes. The growth of the global Spinal cord Stimulation market is driven by a number of factors that include rise in ageing demographics, rising healthcare expenditure per capita, growing cases of obesity and increasing number of failed surgeries. Acknowledging these factors, it could be said that the Spinal cord Stimulation market business will certainly gain importance in the years to come. Strict regulations, environment issues, dearth of expertise and trained healthcare workers and several other issues pose major challenge to the growth of this business. Major trends prevailing in the spinal cord stimulation market are advancement in spine surgery, changing surgeon preferences, mergers & acquisitions and incidence of pain conditions in the US households. Company Coverage - Boston Scientific - Nevro - St. Jude Medical - Medtronic Key Topics Covered: 1. Executive Summary 2. Spinal Cord Injuries and Stimulation: An Introduction 3. Global Spinal Cord Stimulation Market Analysis 4. Spinal Cord Stimulation Market: Segment Analysis 5. The US Spinal Cord Stimulation Market 6. Global Spinal Cord Stimulation Market dynamics 8. Competitive Landscape: Spinal Cord Stimulation Market 9. Company Profiles: Spinal Cord Stimulation Market For more information visit http://www.researchandmarkets.com/research/t3...bal_spinal
BSX: 14.98 (+0.24), MDT: 75.26 (+0.33), STJ: 67.48 (+0.65)
Look for Shares of St Jude Medical to Potentially Rebound after Yesterday's 2.20% Sell Off
Comtex SmarTrend(R) - Fri Feb 06, 4:16PM CST
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $65.95 to a high of $67.98. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $66.31 on volume of 3.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
STJ: 67.48 (+0.65)
SmarTrend Watching for Potential Rebound in Shares of St Jude Medical After 2.20% Loss
Comtex SmarTrend(R) - Fri Feb 06, 4:15PM CST
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $65.95 to a high of $67.98. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $66.31 on volume of 3.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
STJ: 67.48 (+0.65)
Insider Trading Alert - BERY, STJ And FLXS Traded By Insiders
at The Street - Thu Feb 05, 11:17AM CST
Stocks with insider trader activity include BERY, STJ and FLXS
BERY: 34.98 (+0.03), FLXS: 31.00 (unch), STJ: 67.48 (+0.65)
Hansen Medical Announces Expanded Protocol for the ARTISAN AF IDE Study
Marketwired - Thu Feb 05, 8:01AM CST
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced FDA approval of an expanded protocol for the ARTISAN-AF IDE Study. The amended protocol now includes the use of the Thermocool(R) SmartTouch(R) Catheter (BioSense Webster, Diamond Bar, CA) and the EnSite Velocity Cardiac Mapping System (St. Jude Medical, St. Paul, MN). These technologies are used in conjunction with the Sensei(R) Robotic System to complete ablation procedures for the treatment of paroxysmal atrial fibrillation per the IDE study protocol.
HNSN: 1.05 (+0.02), STJ: 67.48 (+0.65)
Global Electrophysiology Devices Industry Report 2015 - Forecasts to 2020
M2 - Thu Feb 05, 6:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/v7rdl9/global) has announced the addition of the "Global Electrophysiology Devices Industry Report 2015" report to their offering. The Global Electrophysiology Devices Industry Report 2015 is a professional and in-depth study on the current state of the electrophysiology devices Industry with a focus on the Chinese situation. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The electrophysiology devices market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Electrophysiology devices industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on thirteen industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The electrophysiology devices industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: - Electrophysiology Devices Industry Overview - Electrophysiology Devices International and China Market Analysis - Electrophysiology Devices Technical Data and Manufacturing Plants Analysis - Electrophysiology Devices Production by Regions by Technology by Applications - Electrophysiology Devices Manufacturing Process and Cost Structure - Electrophysiology Devices Productions Supply Sales Demand Market Status and Forecast 2009-2014 - Electrophysiology Devices Key Manufacturers Analysis - Up and Down Stream Industry Analysis - Electrophysiology Devices Marketing Channels Analysis - Electrophysiology Devices Industry Development Trend - Electrophysiology Devices Industry Development Proposals - Electrophysiology Devices New Project Investment Feasibility Analysis - Global and China Electrophysiology Devices Industry Research Conclusions Companies Mentioned - Biotronik - Boston Scientific - GE Healthcare - HTONG - Huanan Medical - JJET - Johnson & Johnson - Medtronic Inc - Micro Port - Natus - Nihon Kohden - Philips Healthcare - St. Jude Medical,Inc. For more information visit http://www.researchandmarkets.com/research/v7rdl9/global
BSX: 14.98 (+0.24), JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), STJ: 67.48 (+0.65)
